Eargo Inc. (NASDAQ: EAR) will release its third-quarter financial results after market close on November 19, 2020. The company will host a conference call and webcast at 1:30 p.m. PT to discuss these results and recent highlights. Eargo focuses on enhancing life quality for those with hearing loss through innovative, virtually invisible hearing aids that are rechargeable and affordable, being approximately half the cost of traditional options. Their latest product, the Eargo Neo HiFi, launched in January, promises better audio fidelity and bandwidth.
Eargo, a medical device company focused on hearing loss, has successfully completed its initial public offering (IPO) of 9,029,629 shares at $18.00 per share, grossing approximately $162.5 million. The offering included the full exercise of an underwriters' option for 1,177,777 additional shares. Eargo's shares began trading on the Nasdaq Global Select Market under the ticker symbol EAR on October 16, 2020. J.P. Morgan and BofA Securities led the offering with Wells Fargo Securities and William Blair as co-managers.
Eargo has announced the pricing of its initial public offering (IPO) of 7,851,852 shares of common stock at $18.00 per share, aiming to raise approximately $141.3 million. The company has granted underwriters a 30-day option to purchase an additional 1,177,777 shares. Eargo's shares will begin trading on the Nasdaq under the ticker symbol EAR on October 16, 2020. The IPO's closing is expected on October 20, 2020, subject to standard closing conditions.